Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Kerman

Showing results (41-50 of 135) with videos related to

Pageof 14
Sort By:
Transplantation Proceedings|March 1, 1981
Prolonged allograft survival of strong pretransplant immune responders treated with ATGR H Kerman, M Floyd, C T Van Buren, et al.
Transplantation Proceedings|September 1, 1978
Predictive value of active T-RFC in renal allograft survivalR H Kerman, T S Ing, J E Hano, et al.
Transplantation Proceedings|September 1, 1981
Prediction of cadaveric allograft survival based on pretransplant nonspecific immunocompetenceR H Kerman, M Floyd, C T Van Buren, et al.
Transplantation|December 1, 1980
Improved allograft survival of strong immune responder-high risk recipients with adjuvant antithymocyte globulin therapyR H Kerman, M Floyd, C T Van Buren, et al.
Transplantation|January 1, 1984
Successful transplantation of cyclosporine-treated haploidentical living-related renal recipients without blood transfusionsS M Flechner, R H Kerman, C Van Buren, et al.
Transplantation Proceedings|February 1, 1989
Interleukin-2 receptor as an immunodiagnostic tool to differentiate rejection from nephrotoxicityA Y Smith, F Citterio, M Welsh, et al.
Transplantation|January 1, 1988
Successful transplantation of 100 untransfused cyclosporine-treated primary recipients of cadaveric renal allograftsR H Kerman, C T Van Buren, R M Lewis, et al.
Transplantation Proceedings|June 1, 1988
Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipientsR H Kerman, C T Van Buren, R M Lewis, et al.
Clinical Transplants|January 1, 1988
Blood transfusion experience for cyclosporine/prednisone-treated renal allograft recipients at the University of Texas Medical School at HoustonR H Kerman, C T Van Buren, R M Lewis, et al.
Tissue Antigens|December 19, 2007
DRB1*1613N: a novel DRB1 allele with a premature termination codonW Zhao, E Guerrero, R H Kerman, et al.
Pageof 14

Showing results (41-50 of 135) with videos related to

Sort By:
Pageof 14
Transplantation Proceedings|March 1, 1981
Prolonged allograft survival of strong pretransplant immune responders treated with ATGR H Kerman, M Floyd, C T Van Buren, et al.
Transplantation Proceedings|September 1, 1978
Predictive value of active T-RFC in renal allograft survivalR H Kerman, T S Ing, J E Hano, et al.
Transplantation Proceedings|September 1, 1981
Prediction of cadaveric allograft survival based on pretransplant nonspecific immunocompetenceR H Kerman, M Floyd, C T Van Buren, et al.
Transplantation|December 1, 1980
Improved allograft survival of strong immune responder-high risk recipients with adjuvant antithymocyte globulin therapyR H Kerman, M Floyd, C T Van Buren, et al.
Transplantation|January 1, 1984
Successful transplantation of cyclosporine-treated haploidentical living-related renal recipients without blood transfusionsS M Flechner, R H Kerman, C Van Buren, et al.
Transplantation Proceedings|February 1, 1989
Interleukin-2 receptor as an immunodiagnostic tool to differentiate rejection from nephrotoxicityA Y Smith, F Citterio, M Welsh, et al.
Transplantation|January 1, 1988
Successful transplantation of 100 untransfused cyclosporine-treated primary recipients of cadaveric renal allograftsR H Kerman, C T Van Buren, R M Lewis, et al.
Transplantation Proceedings|June 1, 1988
Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipientsR H Kerman, C T Van Buren, R M Lewis, et al.
Clinical Transplants|January 1, 1988
Blood transfusion experience for cyclosporine/prednisone-treated renal allograft recipients at the University of Texas Medical School at HoustonR H Kerman, C T Van Buren, R M Lewis, et al.
Tissue Antigens|December 19, 2007
DRB1*1613N: a novel DRB1 allele with a premature termination codonW Zhao, E Guerrero, R H Kerman, et al.
Pageof 14